Innoveren Scientific Inc., a medical bioscience company that develops technology in regenerative medicine for limb salvage. It is also developing immunotherapies for ovarian cancer, pancreatic cancer, and mesothelioma. The company was formerly known as H-CYTE, Inc. and changed its name to Innoveren Scientific Inc. in July 2023. The company is based in Cincinnati, Ohio.
Frequently asked questions
What sector does Innoveren Scientific Inc. (IVRN) operate in?
Innoveren Scientific Inc. belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Innoveren Scientific Inc. (IVRN) current stock price?
As of the latest data, Innoveren Scientific Inc. stock price is $0.00, with a previous close of $0.00.
What is Innoveren Scientific Inc. (IVRN) current market capitalization?
Innoveren Scientific Inc. market cap is approximately 1.40 thousand.
What is Innoveren Scientific Inc. (IVRN) Earnings Per Share (EPS)?
The trailing EPS is -$5.52.
Does Innoveren Scientific Inc. (IVRN) pay dividends?
No. Innoveren Scientific Inc. does not pay a dividend.
What is Innoveren Scientific Inc. (IVRN) beta (volatility) score?
Innoveren Scientific Inc. has a beta of 467.439, indicating very high volatility compared to the market.